Convection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and PEGylated liposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenografts
Open Access
- 1 October 2007
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 9 (4), 393-403
- https://doi.org/10.1215/15228517-2007-019
Abstract
We have previously shown that convection-enhanced delivery (CED) of highly stable nanoparticle/liposome agents encapsulating chemotherapeutic drugs iKeywords
This publication has 40 references indexed in Scilit:
- Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts1Neuro-Oncology, 2007
- Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model1Neuro-Oncology, 2006
- Novel Nanoliposomal CPT-11 Infused by Convection-Enhanced Delivery in Intracranial Tumors: Pharmacology and EfficacyCancer Research, 2006
- Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agentsJournal of Neurosurgery, 2005
- Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brainExperimental Neurology, 2005
- Convection-Enhanced Delivery of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand with Systemic Administration of Temozolomide Prolongs Survival in an Intracranial Glioblastoma Xenograft ModelCancer Research, 2004
- Drug Delivery Systems: Entering the MainstreamScience, 2004
- The blood-brain and blood-tumor barriers: A review of strategies for increasing drug deliveryNeuro-Oncology, 2000
- The blood-brain and blood-tumor barriers: A review of strategies for increasing drug deliveryNeuro-Oncology, 2000
- HSP70 Overexpression Mediates the Escape of a Doxorubicin-Induced G2 Cell Cycle ArrestBiochemical and Biophysical Research Communications, 1996